[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.208.185. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 282
Citations 0
Correction
August 2018

Error in Figure Label and Caption

JAMA Oncol. 2018;4(8):1139. doi:10.1001/jamaoncol.2018.1995

In the Original Investigation titled “Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers,”1 published online April 19, 2018, there was an error in the Figure caption. Where it previously read “A, Breast cancer incidence among BRCA1 mutation carriers who used estrogen-alone HRT compared with women who did not use HRT” it now correctly reads “A, Breast cancer incidence among BRCA1 mutation carriers who used any HRT compared with women who did not use HRT.” The panel label for part A of the Figure was also corrected. This article was corrected online.

References
1.
Kotsopoulos  J, Gronwald  J, Karlan  B,  et al.  Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers [published online April 19, 2018].  JAMA Oncol. doi:10.1001/jamaoncol.2018.0211Google Scholar
×